Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05786417
PHASE4

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).

Official title: A Trial Comparing the Effectiveness and Tolerability of Medications in Older Adults With Stable Angina and Multiple Chronic Conditions: LIVEBETTER

Key Details

Gender

All

Age Range

65 Years - Any

Study Type

INTERVENTIONAL

Enrollment

741

Start Date

2023-05-10

Completion Date

2027-05-30

Last Updated

2026-04-07

Healthy Volunteers

No

Interventions

OTHER

Clinician Discretion

Clinician discretion as to which BB or CCB will be used if the participant has a heart rate and blood pressure within normal limits.

DRUG

Beta blocker

Selection of the specific BB and initial starting dose will be determined by the treating clinician.

DRUG

Calcium channel blocker

Selection of the specific CCB and initial starting dose will be determined by the treating clinician.

Locations (10)

Yale School of Medicine

New Haven, Connecticut, United States

Wellstar Research Institute

Marietta, Georgia, United States

Cook County Health

Chicago, Illinois, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

Mt. Sinai Health System

New York, New York, United States

NYC Health and Hospitals, Harlem Hospital

New York, New York, United States

Nirvana Integrative Medicine

New York, New York, United States

Duke University, School of Medicine

Durham, North Carolina, United States

Cleveland Clinic

Cleveland, Ohio, United States

Inova Health Care Services

Fairfax, Virginia, United States